MEP1A and pancreatic neoplasm: The heightened expression of dihydropyrimidine dehydrogenase (DPYD) in pancreatic cancer not only accelerates pyrimidine degradation but also stimulates cell proliferation and invasiveness, accompanied by the upregulation of MMP9 and MEP1A.